EVALUATION OF HEPARANASE PROCOAGULANT ACTIVITY AND TISSUE FACTOR PATHWAY INHIBITOR LEVEL IN UTERINE CANCER PATIENTS
Shaala, I., Deghady, A., Meheissen, M., Hussien, E. (2023). EVALUATION OF HEPARANASE PROCOAGULANT ACTIVITY AND TISSUE FACTOR PATHWAY INHIBITOR LEVEL IN UTERINE CANCER PATIENTS. EKB Journal Management System, 5(1), 16-17. doi: 10.21608/alexpo.2023.191344.1553
Iglal Shaala; Akram Abdelmoneim Deghady; Mohamed Ahmed Meheissen; Esraa Mohammed Hussien. "EVALUATION OF HEPARANASE PROCOAGULANT ACTIVITY AND TISSUE FACTOR PATHWAY INHIBITOR LEVEL IN UTERINE CANCER PATIENTS". EKB Journal Management System, 5, 1, 2023, 16-17. doi: 10.21608/alexpo.2023.191344.1553
Shaala, I., Deghady, A., Meheissen, M., Hussien, E. (2023). 'EVALUATION OF HEPARANASE PROCOAGULANT ACTIVITY AND TISSUE FACTOR PATHWAY INHIBITOR LEVEL IN UTERINE CANCER PATIENTS', EKB Journal Management System, 5(1), pp. 16-17. doi: 10.21608/alexpo.2023.191344.1553
Shaala, I., Deghady, A., Meheissen, M., Hussien, E. EVALUATION OF HEPARANASE PROCOAGULANT ACTIVITY AND TISSUE FACTOR PATHWAY INHIBITOR LEVEL IN UTERINE CANCER PATIENTS. EKB Journal Management System, 2023; 5(1): 16-17. doi: 10.21608/alexpo.2023.191344.1553